Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges.

Abstract excerpt

The myelodysplastic syndromes (MDS) are a heterogeneous constellation of hematologic malignancies characterized by aberrant differentiation and clonal expansion of abnormal myeloid cells that initially manifest with ineffective hematopoiesis and consequent cytopenias. The prognosis of MDS is variable and depends on clinical and hematologic parameters, cytogenetic and molecular findings, as well as comorbidities....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clonal Hematopoiesis
• Share to Mutation
• Share to Myelodysplastic Syndromes